Skip to content
Start here: prostate cancer, from screening to recurrence episode artwork

Sep 20, 2026 18 min

Start here: prostate cancer, from screening to recurrence

from FRCS in 15

The best place to begin: the highest-yield topic in the exam, at the pace the rest of the series runs. What the screening trials really show and why they only look contradictory, the MRI-first pathway and biparametric scanning, why the biopsy left the operating theatre, the T2 change people miss, who actually needs staging imaging, why three surgery-versus-monitoring trials disagree, when a benign biopsy is not reassuring, and the two recurrence definitions you must not mix up.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Start here: prostate cancer, from screening to recurrence

0:00 18:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of FRCS in 15?

This episode is 18 minutes long.

When was this FRCS in 15 episode published?

This episode was published on September 20, 2026.

Can I download this FRCS in 15 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.